Skip to main content
. 2022 Jun 6;12:847957. doi: 10.3389/fonc.2022.847957

Figure 2.

Figure 2

Survival curve of different prognostic factors of 84 patients with TETs. Cumulative survival according to completion of sex (A), age (B), maximum tumor diameter (C), surgery (D), chemotherapy (E), radiotherapy (F), WHO histological classification (G), Masaoka–Koga stage (H), and 8th UICC/AJCC TNM staging (I).